Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Heterotaxy Syndrome

ClinicalTrials.gov lists 5 trials for Heterotaxy Syndrome or a narrower condition beneath it.

MeSH D059446 Cardiovascular Diseases C14 C15 C16
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Observational Observational 4 Phase 1 Phase 1 1 Observational Observational 4

Trials per phase

5 of the 5 trials are tagged with Heterotaxy Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Heterotaxy Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Heterotaxy Syndrome trials start? (5)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Observational

Top of scale: 1

1990: 1 trials (Observational 1) 2009: 1 trials (Observational 1) 2012: 1 trials (Observational 1) 2013: 1 trials (Observational 1) 2014: 1 trials (Phase 1 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2014 1
2013 1
2012 1
2009 1
1990 1

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 5 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Heterotaxy Syndrome trials in? (2)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Observational 4

How many Heterotaxy Syndrome trials are recruiting? (3)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 1
Completed 3
Terminated 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which publications cover Heterotaxy Syndrome? (9)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Prevalence (4)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Visceral heterotaxy Prevalence at birth 1-5 / 10 000 United States US Exact
Visceral heterotaxy Prevalence at birth 1-5 / 10 000 United States US Exact
Visceral heterotaxy Point prevalence 1-9 / 100 000 Europe Not stated Exact
Visceral heterotaxy Point prevalence 1-9 / 100 000 Europe Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Visceral heterotaxy 450 Exact Orphadata Science knowledge files, Product 1
Visceral heterotaxy 450 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages